Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560014 · ClinicalTrials.gov registry record · NA
Nutrient Levels Alter Transplant Outcome
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00560014 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 54 participants.
The verdict
NCT00560014, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.
Interventions
- DIETARY_SUPPLEMENT Arginine and canola oil
- DIETARY_SUPPLEMENT Coromega and Arginine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 1997-09 |
| Est. Completion | 2005-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00560014
The ClinicalTrials.gov registry entry for NCT00560014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arginine and canola oil is the first listed.
NCT00560014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00560014 about?
NCT00560014 is a clinical study titled "Nutrient Levels Alter Transplant Outcome". The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with argin...
What is the current status of trial NCT00560014?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 1997-09. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00560014?
The interventions under investigation include: Arginine and canola oil (DIETARY_SUPPLEMENT), Coromega and Arginine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00560014?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.